Complex Partial Seizures

• FDA approval · 2019-09-12
  FDA Approved: VIGABATRIN — Supplemental Application (Dr. Reddys Laboratories Inc.,)

  FDA approved a supplemental application for Vigabatrin submitted by Dr. Reddy's Laboratories Inc., enabling continued availability of the ge…

• FDA approval · 2019-07-31
  FDA Approved: SABRIL — Supplemental Application (Lundbeck Pharmaceuticals LLC)

  FDA approved a supplemental application for SABRIL (vigabatrin) submitted by Lundbeck Pharmaceuticals LLC.

• FDA approval · 2019-01-14
  FDA Approved: VIGABATRIN — Original Application (Actavis Pharma, Inc.)

  FDA page documents Actavis Pharma's original application for a generic Vigabatrin product, seeking approval to market a generic version.

• FDA approval · 2018-06-21
  FDA Approved: VIGADRONE — Original Application (Upsher-Smith Laboratories, LLC)

  FDA approved the original generic application for Vigabatrin under the brand VIGADRONE by Upsher-Smith Laboratories, expanding access to the…

• FDA approval · 2017-04-27
  FDA Approved: VIGABATRIN — Original Application (Par Health USA, LLC)

  FDA approves Vigabatrin original Abbreviated New Drug Application for Par Health USA, LLC (generic entry).

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2011-01-18
  FDA Approved: SABRIL — Supplemental Application (Lundbeck Pharmaceuticals LLC)

  FDA approved a supplemental application for Sabril (vigabatrin) submitted by Lundbeck Pharmaceuticals LLC.

• FDA approval · 2009-08-21
  FDA Approved: SABRIL — Original Application (Lundbeck Pharmaceuticals LLC)

  FDA approved Sabril (vigabatrin) from Lundbeck as an original NDA for the treatment of infantile spasms and refractory complex partial seizu…